Enwei Pharmaceutical's Controlling Shareholder Unfreezes 138,000 Shares, Cumulative Frozen Shares Reduced to Zero

Corporate Action
โดย 财中社·Read original
Summary · why it matters

Enwei Pharmaceutical's controlling shareholder, Chengdu Enwei Investment Group, has had 138,000 shares unfrozen, representing 0.53% of its holdings and 0.13% of the company's total share capital. As a result, the cumulative number of frozen shares held by the controlling shareholder and its concert parties has been reduced to zero. In the first quarter of 2026, the company achieved revenue of 175 million yuan and net profit attributable to the parent company of 12.5 million yuan.

Impact on stocks 1

Others · 1 stocks